Protalix Biotherapeutics For a Monster 180% Win!

TO READ THE FULL STORY SUBSCRIBE OR SIGN IN

The Computer and Technology portfolio is up more than 440% in the last 6 months! Get these stock picks and more by signing up for the premium service.

Analyst Actions and Breaking News

Overnight Analyst Actions:

Raised: None

Initiates: None

Cuts: None

Overnight Headlines By Ticker:

PLX Protalix Biotherapeutics Inc

12/27 07:30 Receives confirmation of order for over $24M of alfataliglicerase to treat gaucher patients in Brazil

PTLA Portola Pharmaceuticals

12/27 07:49 Price Target raised to $29 from $20 at Credit Suisse, reiterates Neutral rating

SGEN Seattle Genetics

12/27 08:00 Announces clinical hold on several Phase 1 trials of Vadastuximab Talirine after deaths [SELL NO LONGER COVERING]

12/27 07:55 Trading halted; news pending; to resume trading at 08:30ET

Stock Market Forecast For Week of December 19 2016

A weekly Saturday night financial show that attempts to predict market direction for the week ahead by looking at a variety of technical and fundamental indicators. This week's show includes commentary on the Fed's first and only rate hike in 2016, Eli Lilly's long-acting Basal Insulin that's now available in the US, takeover rumors circulating about Qorvo, Protalix Biotherapeutics $24 million order to treat Gaucher patients in Brazil, the FDA approval of Vericel's Maci for the repair of cartilage defects of the knee, Silicon Motion's supplying of SSD solutions to the Alibaba Group, and more.